Nova Patents
IL178384A0

Improved formulations of 6-mercaptopurine

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

43 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
55847704United States of AmericaP
2005011112United States of AmericaW

Members43

Family members, oldest first
DocumentOfficeKind
AU2005232582A1AustraliaA1
AU2005232583A1AustraliaA1
CA2560654A1CanadaA1
CA2560997A1CanadaA1
WO2005099665A2World Intellectual Property Organization (WIPO)A2
WO2005099666A2World Intellectual Property Organization (WIPO)A2
US2006008520A1United States of AmericaA1
US2006009473A1United States of AmericaA1
TW200602061ATaiwan Province of ChinaA
TW200602062ATaiwan Province of ChinaA
EP1729727A2European Patent Office (EPO)A2
WO2005099666A3World Intellectual Property Organization (WIPO)A3
WO2005099665A3World Intellectual Property Organization (WIPO)A3
KR20070007133ARepublic of KoreaA
EP1746975A2European Patent Office (EPO)A2
IL178383A0IsraelA0
IL178384A0This recordIsraelA0
KR20070026438ARepublic of KoreaA
MXPA06011316AMexicoA
MXPA06011317AMexicoA
EA200601596A1Eurasian Patent Organization (EAPO)A1
EA200601597A1Eurasian Patent Organization (EAPO)A1
CN101065114AChinaA
JP2007530692AJapanA
JP2007530693AJapanA
CN101146520AChinaA
US2009042914A1United States of AmericaA1
AU2005232583B2AustraliaB2
AU2005232582B2AustraliaB2
KR20090081437ARepublic of KoreaA
KR100930329B1Republic of KoreaB1
KR20100045528ARepublic of KoreaA
US8188067B2United States of AmericaB2
US2012207841A1United States of AmericaA1
US8653060B2United States of AmericaB2
US2014161888A1United States of AmericaA1
IL178384AIsraelA
US2015290133A1United States of AmericaA1
US9180097B2United States of AmericaB2
US9375403B2United States of AmericaB2
US2016296473A1United States of AmericaA1
EP1729727B1European Patent Office (EPO)B1
US10525009B2United States of AmericaB2